NCI SBIR Overview & Upcoming Funding Opportunities

BioEnterprise, BioOhio, and the National Cancer Institute Small Business Innovation Research Development Center invite you to attend this upcoming seminar to learn about new non-dilutive funding opportunities available for early-stage companies. The session will cover current and upcoming changes to the SBIR & STTR programs, practical strategies for developing successful proposals, other NCI resources offered to accelerate drug development and commercialization, and the latest funding opportunities from other government sources, such as the Department of Defense and BARDA. This event is free to attend.

Agenda

1:00 – 2:00 PM – Presentation by Ming Zhao, PhD, Program Director, NCI SBIR Development Center

This session will provide an overview of:

• Overview of SBIR/STTR eligibility requirements
• NIH SBIR/STTR process
• Practical strategies on how to successfully submit competitive research proposals
• Audience Q&A

 

2:00 – 2:15 PM – Presentation by Liz Powell and Becky Watts, G2G Consulting

This session will provide an overview of:

• Funding landscape for biosciences beyond SBIRs
• Key agencies for biosciences to target
• Timelines to follow
• Process for applying for non-SBIR grants
• Case studies in obtaining government funding

 

2:15 – 5:30 PM – One-on-one meetings with Dr. Zhao and G2G. Meeting times will be in 15 minute increments.

Opportunities for one-on-one meetings with Dr. Zhao and/or G2G are available. If interested in scheduling a one-on-one meeting, please complete an application prior to August 25. Since there are a limited number of one-on-one meeting times, not all applications are guaranteed a slot.

 

For more information or to register, click here.

Where: